Inside IPEC - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Inside IPEC

Inside IPEC: IPEC Tackles Monographs, Impurities, Particles, and More

December 2, 2011

Pharmaceutical Technology

As the excipient supply chain becomes more complex, industry must up the ante to comply with new standards and regulations.

Inside IPEC: IPEC–Americas Releases Good Distribution Practices Audit Guide

March 2, 2011

Pharmaceutical Technology

A new audit guide aims to improve supply-chain security and supplier qualification practice.

Inside IPEC: Global Initiatives to Expand to Latin America

December 2, 2010

Pharmaceutical Technology

IPEC extends its reach to Brazil and Argentina in an effort to harmonize excipient best practices.

Inside IPEC–Americas: Evaluating Excipient Stability

September 2, 2009

Pharmaceutical Technology

IPEC's new stability testing guide takes into account the full supply chain's storage conditions.

Inside IPEC: Good Distribution Practices for Pharmaceutical Excipients

May 2, 2009

Pharmaceutical Technology

The GDP committee of IPEC–Europe is trying to seal one more broken link in the supply chain. This article contains bonus online-exclusive material.

Inside IPEC: Regulation for Excipients is Brewing Across the Atlantic

February 2, 2009

Pharmaceutical Technology

Without any GMP guidelines for excipients in Europe, change can't come soon enough for some industry groups.

IPEC's New Safety Evaluation Procedure: A Q&A with IPEC Chairman Dave Schoneker

November 2, 2008

Pharmaceutical Technology

IPEC Chairman Dave Schoneker discusses current efforts toward facilitating regulatory reviews of new excipients.

Inside IPEC: Dual-Use Labeling

July 2, 2008

Pharmaceutical Technology

Clear labels for substances that can be used as excipients, APIs, or both are critical to end-product use.

Inside IPEC–Americas: Excipient Audits and API Audits are Worlds Apart

May 2, 2008

Pharmaceutical Technology

The less complex nature of excipient manufacturers, as compared with API manufactures, carries many benefits.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
22%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
37%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here